Fricke and colleagues in a study used VEGF-trap for a number of advanced-stage cancer patients and found the efficacy of this strategy in improving DC maturation; however, the efficacy of this approach cannot be achieved unless reducing the number of MDSCs as well (114). The gene discussed is VEGFA; the disease is cancer.